arrow
M

Mark R. Conaway

University of Virginia
H指数:75
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Preterm Birth Increases Susceptibility to Hyperglycemia-Induced Kidney Injury With Sex-Specific Differences in Structural and Molecular Responses

早产增加了对高血糖诱导的肾脏损伤的易感性,且在结构和分子反应上存在性别特异性差异

2026-04-200
OAAI
Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 factorial, superiority trial

坦桑尼亚和乌干达HIV相关败血症的即时或大剂量抗结核治疗 (ATLAS): 一项3期、开放标签、随机、对照、2 × × 2析因、优越性试验

2026-01-280
PREAI
Regadenoson in the rehabilitation of marginal donor lungs on ex vivo lung perfusion: A blinded multicenter randomized controlled clinical trial

Fleischmann, E.; Conaway, M.; Rabin, J.; Vecere, K.; Masih, K.; Zhao, Y.; Zhang, A.; Khan, M.; Mas, V.; Krupnick, A.; 等. Regadenoson在体外肺灌注下边缘供体肺康复中的应用:一项盲法多中心随机对照临床试验. JTCVS Open 2025. [Google Scholar] [CrossRef]

2025-12-011
OAAI
Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology Drugs

采用定量方法优化肿瘤药物新组合及后续适应症的剂量

2025-06-050
PRE
Pharmacokinetic-Pharmacodynamic Determinants of Clinical Outcomes for Rifampin-Resistant Tuberculosis: A Multisite Prospective Cohort Study
2022-06-226
OAAI
A cluster randomized controlled trial for a multi-level, clinic-based smoking cessation program with women in Appalachian communities: study protocol for the Break Free program (vol 17, 11, 2022)
2022-04-010
OAAI
A cluster randomized controlled trial for a multi-level, clinic-based smoking cessation program with women in Appalachian communities: study protocol for the Break Free program
2022-02-144
OAAI